Skip to main content

Table 1 Descriptive characteristics of patients by multimorbidity or non-multimorbidity group (1,749,710 adult patients, Catalonia, 2010)

From: The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study

  Multimorbidity group Non-multimorbidity group Total
  Cardiovascular morbidity Non-cardiovascular morbidity   
Variables (n = 442,816) (n = 375,355) (n = 931,539) (N = 1,749,710)
Age (years) 65.7 (14.6) 48.2 (15.4) 38.3 (12.7) 47.4 (17.8)
Sex (% females) 56.1 57.5 45.5 50.7
Number of chronic diseases (median, IQR) 5.0 (3.0;7.0) 3.0 (2.0;4.0) 0.0 (0.0;1.0) 1.0 (0.0;3.0)
Visits (median, IQR) 10.0 (6.0;18.0) 6.0 (3.0;11.0) 1.0 (0.0;4.0) 4.0 (1.0;9.0)
Urban setting (%) 83.4 84.0 84.2 84.0
Physical examination
 BMI (kg/cm2) (n= 509,368) 29.7 (5.1) 28.0 (5.4) 26.0 (4.7) 28.3 (5.3)
 Systolic BP (mm Hg) (n = 773,446) 135.2 (16.2) 126.6 (14.6) 123.8 (14.9) 129.7 (16.3)
 Diastolic BP (mm Hg) (n = 774,139) 76.7 (10.3) 76.0 (9.6) 74.5 (10.1) 75.9 (10.1)
Laboratory tests
 Glycated haemoglobin (%)(SD) (n = 208,581) 6.6 (1.3) 6.3 (1.5) 5.7 (1.2) 6.4 (1.4)
 Creatinine (mg/dl) (SD) (n = 738,083) 0.9 (0.4) 0.8 (0.2) 0.8 (0.2) 0.9 (0.3)
 Uric acid (mg/dl) (SD) (n = 475, 334) 5.5 (1.6) 4.8 (1.4) 4.8 (1.4) 5.2 (1.5)
 Total cholesterol (mg/dl) (SD) (n = 745,010) 202.0 (39.7) 209.0 (40.6) 194.3 (38.4) 201.8 (40.0)
 Triglycerides (mg/dl) (SD) (n = 190,159) 132.9 (82.9) 129 (98.7) 113.3 (75.7) 127.5 (86.4)
 Glomerular filtration rate < 60 % (%) (n = 544,438) 17.6 3.2 1.3 9.2
  1. p-values overall between multimorbidity and non-multimorbidity groups were significant for all variables (p < 0.001)